ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    MY-ATLAS: A Novel Simulation Algorithm for Liver Transplant Allocation

    C. G. Rickert1, H. Zhao2, Z. Leung2, M. Akan3, J. F. Markmann1, S. Tayur3, H. Yeh1

    1Surgery, Massachusetts General Hospital, Boston, MA, 2City University of Hong Kong, Hong Kong, China, 3Tepper School of Business, Carnegie Mellon University, Pittsburgh, PA

    *Purpose: Currently, the primary tool for modeling expected outcomes from changes in allocation policy is the SRTR-run Liver Simulated Allocation Model (LSAM), which is neither…
  • 2020 American Transplant Congress

    Impact of the Baseline Anti-A/B IgG Titer on the Clinical Outcome in ABO-Incompatible Liver Transplantation

    J. Lee1, E. Kim1, S. Yang1, D. Kim2, M. Ju3, J. Lee1, M. Kim1, S. Kim1, D. Joo1

    1Department of Transplantation Surgery, Severance Hospital, Seoul, Korea, Republic of, 2Department of Surgery, Yonsei University Wonju College of Medicine, Wonju, Korea, Republic of, 3Department of Surgery, Gangam Severance Hospital, Seoul, Korea, Republic of

    *Purpose: The use of ABO incompatible (ABOi) living donors is an attractive solution for expanding the liver donor pool. We investigated the impact of the…
  • 2020 American Transplant Congress

    Predictors and Outcomes of Acute Graft versus Host Disease after Liver Transplant

    A. Caines1, D. Moonka2, S. Nagai3, R. Salgia2

    1Gastroenterology and Hepatology, Henry Ford Health System, Detroit, MI, 2Hepatology, Henry Ford Health System, Detroit, MI, 3Transplant Surgery, Henry Ford Health System, Detroit, MI

    *Purpose: Graft-versus-Host Disease (GVHD) is a rare complication of liver transplant (LT) with an estimated incidence of 0.1-2% per year and a high mortality. There…
  • 2020 American Transplant Congress

    Higher Probability of Living Donor Liver Transplantation is Associated with DSAs Having a Higher Median Meld at Transplant

    D. Haakinson1, S. Noreen2, D. Stewart2, R. Batra1, G. Gan1, Y. Deng1, S. Kulkarni1

    1Yale, New Haven, CT, 2UNOS, Richmond, VA

    *Purpose: Recent studies show that outcomes of living donor liver transplantation (LDLT) are superior compared to those receiving deceased donor grafts. Access to deceased donor…
  • 2020 American Transplant Congress

    A Comprehensive Evaluation of Risk Factors for Pneumocystis Jiroveci Pneumonia in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis

    N. Permpalung1, V. Kittipibul2, P. Mekraksakit3, P. Rattanawong4, S. Nematollahi1, S. Mehta-Steinke1

    1Johns Hopkins University School of Medicine, Baltimore, MD, 2University of Miami/Jackson Memorial Hospital, Miami, FL, 3Texas Tech University Health Sciences, Lubbock, TX, 4Mayo Clinic, Phoenix, AZ

    *Purpose: Pneumocytis jiroveci pneumonia (PJP) is an important opportunistic fungal infection in solid organ transplant (SOT) recipients that carries a significant morbidity and mortality. Several…
  • 2020 American Transplant Congress

    Evaluation of Cytomegalovirus Prophylaxis in Low and Intermediate Risk Kidney Transplant Recipients Receiving Lymphocyte-Depleting Induction

    H. Stamps, K. Linder, D. O'Sullivan, F. Cheema, H. Kutzler

    Hartford Hospital, Hartford, CT

    *Purpose: This study evaluates if choice and duration of Cytomegalovirus (CMV) prophylaxis based on donor (D) and recipient (R) CMV serostatus impacts the incidence of…
  • 2020 American Transplant Congress

    Clinical Features and Transplant Outcomes in Kidney Transplant Recipients with Renal Cell Carcinoma

    C. Baek, H. Kim, S. Park

    Asan Medical Center, Seoul, Korea, Republic of

    *Purpose: Previous studies have recommended a 2-5-year waiting time prior to kidney transplantation (KT) in patients with end-stage renal disease (ESRD) and symptomatic renal cell…
  • 2020 American Transplant Congress

    Morbid Obesity: A Growing Barrier to Early Kidney Transplant Wait-Listing in the United States

    L. Lavenburg1, E. Weinhandl2, L. Robinson3, B. Milliron4, C. Earthman5, A. Klassen3, M. Harhay6

    1University of Pennsylvania, Philadelphia, PA, 2Fresenius Medical Care North America, Minneapolis, MN, 3Drexel University Dornsife School of Public Health, Philadelphia, PA, 4Drexel University College of Nursing and Health Professions, Philadelphia, PA, 5University of Delaware, Newark, DE, 6Drexel University College of Medicine, Philadelphia, PA

    *Purpose: Kidney transplant (KT) programs may be more reluctant to accept transplant candidates with morbid obesity due to concerns about higher post-operative risks. We examined…
  • 2020 American Transplant Congress

    Ready for Transplantation: Getting the Right Messages Across at the Right Time

    D. Goodall, K. Tansey, S. Clarke-Swaby, P. Webster, E. Salisbury, J. Tomlinson, R. Bright, W. Brown

    Imerial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, United Kingdom

    *Purpose: Successful outcomes post-transplantation demands significant commitment from patients therefore it is crucial that they have a good understanding of what is involved. Our pharmacist…
  • 2020 American Transplant Congress

    Remote Steroid Wean is Safe When Compared to Early Wean in Heart Transplant Recipients

    B. C. Salgado, J. Krisl, E. A. Graviss, D. T. Nguyen, A. Bhimaraj, A. Guha

    Cardiovascular Disease, Heart Failure and Transplant, Houston Methodist Hospital, Houston, TX

    *Purpose: The risks and benefits of remote steroid wean in heart transplant recipients is unknown. We compared outcomes in patients undergoing early and remote steroid…
  • « Previous Page
  • 1
  • …
  • 215
  • 216
  • 217
  • 218
  • 219
  • …
  • 223
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences